X-83873171-C-G

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting

The NM_021118.3(CYLC1):​c.463C>G​(p.Gln155Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000319 in 1,202,492 control chromosomes in the GnomAD database, including 2 homozygotes. There are 126 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.00032 ( 2 hom. 121 hem. )

Consequence

CYLC1
NM_021118.3 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.42
Variant links:
Genes affected
CYLC1 (HGNC:2582): (cylicin 1) This gene encodes a sperm head cytoskeletal protein. The encoded protein is associated with the calyx of spermatozoa and spermatids. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009558111).
BS2
High Hemizygotes in GnomAd4 at 5 geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYLC1NM_021118.3 linkc.463C>G p.Gln155Glu missense_variant Exon 4 of 5 ENST00000329312.5 NP_066941.1 P35663Q6PEK4
CYLC1XM_005262086.5 linkc.460C>G p.Gln154Glu missense_variant Exon 4 of 5 XP_005262143.1
CYLC1NM_001271680.2 linkc.174+1601C>G intron_variant Intron 3 of 3 NP_001258609.1 A0A087WXC8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYLC1ENST00000329312.5 linkc.463C>G p.Gln155Glu missense_variant Exon 4 of 5 1 NM_021118.3 ENSP00000331556.4 P35663
CYLC1ENST00000621735.4 linkc.174+1601C>G intron_variant Intron 3 of 3 3 ENSP00000480907.1 A0A087WXC8

Frequencies

GnomAD3 genomes
AF:
0.000261
AC:
29
AN:
110926
Hom.:
0
Cov.:
22
AF XY:
0.000150
AC XY:
5
AN XY:
33416
show subpopulations
Gnomad AFR
AF:
0.0000979
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000579
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000666
Gnomad MID
AF:
0.00424
Gnomad NFE
AF:
0.000285
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000492
AC:
85
AN:
172907
Hom.:
1
AF XY:
0.000432
AC XY:
26
AN XY:
60229
show subpopulations
Gnomad AFR exome
AF:
0.0000821
Gnomad AMR exome
AF:
0.00137
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000175
Gnomad FIN exome
AF:
0.000190
Gnomad NFE exome
AF:
0.000390
Gnomad OTH exome
AF:
0.00282
GnomAD4 exome
AF:
0.000324
AC:
354
AN:
1091512
Hom.:
2
Cov.:
30
AF XY:
0.000338
AC XY:
121
AN XY:
358196
show subpopulations
Gnomad4 AFR exome
AF:
0.000575
Gnomad4 AMR exome
AF:
0.00133
Gnomad4 ASJ exome
AF:
0.0000522
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000227
Gnomad4 FIN exome
AF:
0.000322
Gnomad4 NFE exome
AF:
0.000240
Gnomad4 OTH exome
AF:
0.000896
GnomAD4 genome
AF:
0.000261
AC:
29
AN:
110980
Hom.:
0
Cov.:
22
AF XY:
0.000149
AC XY:
5
AN XY:
33480
show subpopulations
Gnomad4 AFR
AF:
0.0000977
Gnomad4 AMR
AF:
0.000578
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000666
Gnomad4 NFE
AF:
0.000285
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000305
Hom.:
4
Bravo
AF:
0.000567
ExAC
AF:
0.000603
AC:
73

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 30, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.463C>G (p.Q155E) alteration is located in exon 4 (coding exon 4) of the CYLC1 gene. This alteration results from a C to G substitution at nucleotide position 463, causing the glutamine (Q) at amino acid position 155 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.87
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
0.0080
DANN
Benign
0.089
DEOGEN2
Benign
0.0025
T
FATHMM_MKL
Benign
0.0050
N
LIST_S2
Benign
0.46
T
M_CAP
Benign
0.0032
T
MetaRNN
Benign
0.0096
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.1
L
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.29
N
REVEL
Benign
0.031
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.12
B
Vest4
0.026
MVP
0.18
MPC
0.0021
ClinPred
0.0032
T
GERP RS
-9.3
Varity_R
0.047
gMVP
0.0074

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs202086052; hg19: chrX-83128179; COSMIC: COSV61410490; API